JM Lee
, Business Development, Novo
JM is a member of Novo Nordisk’s Global Business Development Transactions team, which is the team that transacts on all material licenses and M&As at Novo Nordisk across all therapeutic areas. Novo Nordisk is a global biopharmaceutical company with a strong focus on metabolic, cardiovascular, and rare diseases in a modality agnostic manner.
JM has previously been a member of business development teams at Bioverativ, Sanofi, and Takeda where her roles at various times included not just transactions but also search & evaluation, diligence & integration, and preclinical program management. Prior to industry business development, she was a consultant at McKinsey & Co. and earned her Ph.D. in Chemistry from MIT.
